Status:
COMPLETED
Continuous Local Anesthetic Infusion Following Hernia Repair
Lead Sponsor:
Endeavor Health
Collaborating Sponsors:
Kimberly-Clark Corporation
Conditions:
Ventral Hernia
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The primary endpoint of this study will determine if subjects receiving a continuous infusion of local anesthetic following laparoscopic ventral hernia repair, with the pain pump installed as describe...
Detailed Description
Patients will be screened to determine study eligibility using inclusion/exclusion criteria. Following the consent process, subjects will be randomly assigned to a treatment arm (anesthetic or placebo...
Eligibility Criteria
Inclusion
- \>18 years
- ASA I,II,III
- Scheduled for Laparoscopic Ventral Hernia Repair
Exclusion
- ASA IV or greater
- Needing emergency surgery
- Known history of drug abuse
- GI, liver, kidney or other condition which, per the surgeon's opinion, could interfere with the absorption, distribution, metabolism or excretion of any drug used during the duration of the study
- Patients with a prior allergic reaction or dependency to morphine, demerol, dilaudid, fentanyl, marcaine(bupivicaine), lidocaine, or ropivicaine.
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01804114
Start Date
March 1 2012
End Date
October 1 2015
Last Update
January 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NorthShore University HealthSystem
Evanston, Illinois, United States, 60201